Unlock instant, AI-driven research and patent intelligence for your innovation.

Bromocriptine composition sustained-release preparation and preparation method thereof

A technology for sustained-release preparations and compositions is applied in the field of sustained-release preparations of bromocriptine compositions and their preparation, and can solve the problems of uncontrollable drug release, fibrosis of bromocriptine, fluctuation of blood drug concentration and the like

Inactive Publication Date: 2014-09-03
HYBIO PHARMA
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, the existing tablets or capsules of bromocriptine are given too frequently, the release of the drug is not easy to control, and it also causes large fluctuations in blood drug concentration, poor effectiveness and compliance, and obvious side effects
Previous studies have found that high-dose bromocriptine may cause fibrosis after long-term use

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Bromocriptine composition sustained-release preparation and preparation method thereof
  • Bromocriptine composition sustained-release preparation and preparation method thereof
  • Bromocriptine composition sustained-release preparation and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0129] Example 1 Screening of Bromocriptine Composition Sustained Release Formulation

[0130] In order to obtain sustained-release preparations with better release uniformity and stability, screening tests were carried out on the types of sustained-release materials, diluents, binders and lubricants. The performance of the obtained bromocriptine composition tablet was evaluated with the sustained-release effect as a reference index.

[0131] Dissolution measurement method: refer to the second method of appendix XC of the 2010 edition of "Chinese Pharmacopoeia", carried out in an automatic dissolution apparatus, the dissolution medium is a phosphate buffer solution with a pH of 6.8, and the temperature of the dissolution medium is 37 ° C ± 5 ° C, The rotation speed is 100rpm / min, and sampling is performed at 10 time points. At the specified sampling time point, absorb 5mL of the solution and filter it, and replenish the same volume of dissolution medium at a temperature of 37°...

Embodiment 2

[0147] Example 2 Preparation of Bromocriptine Composition Sustained Release Tablets

[0148] Preparation of tablets with a strength of 0.7 mg:

[0149] Take the raw and auxiliary materials according to the following formula (according to 1000 preparation units):

[0150]

[0151]Get principal agent bromocriptine, pulverize, cross 40 mesh sieves, obtain fine powder, standby; Get hypromellose (sustained-release material), ethyl cellulose, starch, microcrystalline cellulose and magnesium stearate, Crush them separately and pass through a 40-mesh sieve. Bromocriptine obtained after sieving is evenly divided into 20 equal parts by mass; hypromellose is evenly divided into 20 equal parts by mass; starch is evenly divided into 20 equal parts by mass; Divide into 20 equal portions and set aside. Firstly take 8 parts out of 20 parts obtained by equally dividing bromocriptine, hypromellose, starch and microcrystalline cellulose, mix them, shake at a frequency of 20 times / second fo...

Embodiment 3

[0152] Example 3 Preparation of Bromocriptine Composition Sustained Release Tablets

[0153] Preparation of tablets with a strength of 3.5 mg:

[0154] Take the raw and auxiliary materials according to the following formula (according to 1000 preparation units):

[0155]

[0156]

[0157] Take the main drug bromocriptine, pulverize it, and pass through a 40-mesh sieve to obtain a fine powder for subsequent use; take chitosan, sodium carboxymethylcellulose, pregelatinized starch and calcium stearate, pulverize respectively, and pass through a 40-mesh sieve . The bromocriptine obtained after sieving is evenly divided into 20 equal parts according to the mass; the chitosan is evenly divided into 20 equal parts according to the mass; First take bromocriptine, chitosan and 9 parts of the 20 parts obtained by pregelatinized starch, mix, and mix evenly with a frequency of 20 times / second for 10 minutes; then add bromocriptine, chitosan 5 parts in the 20 parts of pregelatiniz...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of a drug preparation, and discloses a bromocriptine composition sustained-release preparation and a preparation method thereof. The bromocriptine composition sustained-release preparation provided by the invention comprises 10-70 parts of bromocriptine, and 15-60 parts of sustained-release material. The bromocriptine composition sustained-release preparation is good in slow-release effect and stable in blood concentration after administration, the blood concentration can be effectively maintained for a long period of time, the administration times can be greatly reduced, the medication compliance of the patient is improved, and the bromocriptine composition sustained-release preparation is simple in preparation method, and more beneficial to popularization and application of the bromocriptine.

Description

technical field [0001] The invention belongs to the technical field of pharmaceutical preparations, and in particular relates to a sustained-release preparation of a bromocriptine composition and a preparation method thereof. Background technique [0002] Bromocriptine, also known as ergot bromide, bromocriptine mesylate, bromocriptine, bromocriptine, breast suppressant, breast-protecting tune, bromoergocriptine, bromocriptine, bromomesylate bromide Hidden court, bromocriptine A. The chemical name is 2-bromoergokryptine-monomethanesulfonate, the molecular formula is C32H40BrN5O5 CH4O3S, and the molecular weight is 750.70. In June 1978, the US FDA approved Novartis' bromocriptine mesylate for high prolactin Hyperemia-related dysfunction, acromegaly, Parkinson's disease. [0003] Bromocriptine is a dopamine receptor agonist mainly used in the treatment of hyperprolactinemia, acromegaly, Parkinson's disease and diabetes. The mechanism of bromocriptine in the treatment of hyp...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K47/38A61K47/40A61K9/22A61K9/52A61K31/48A61P5/08A61P25/16A61P3/10
Inventor 徐春莲郑春莲陶安进马亚平袁建成
Owner HYBIO PHARMA